Evidence map›Paper›PMID 30737374›Full record

ArticleNature communications2019

Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition.

Jessica Gräb, Isabelle Suárez, Edeltraud van Gumpel, Sandra Winter, Fynn Schreiber, Anna Esser, Christoph Hölscher, Melanie Fritsch, Marc Herb, Michael Schramm and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06875336 (A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06875336 recruitingnot on this mapstarted 2023, after this paper: background citation

A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis

TypeobservationalSponsorUniversity of CologneRan2023 to 2025Enrolled150ConditionsExtrapulmonary TuberculosisArmsbiomarker analysis
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The "yeast-drop" treatment protocol in theFrontiers in tuberculosis · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. MedComm · 2023
    Review
  15. Article
  16. Methylprednisolone PromotesMicroorganisms · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Jessica GräbDepartment I of Internal Medicine, University of Cologne, 50937, Cologne, Germany.
Isabelle SuárezDepartment I of Internal Medicine, University of Cologne, 50937, Cologne, Germany.
Edeltraud van GumpelDepartment I of Internal Medicine, University of Cologne, 50937, Cologne, Germany.
Sandra WinterDepartment I of Internal Medicine, University of Cologne, 50937, Cologne, Germany.
Fynn SchreiberDepartment I of Internal Medicine, University of Cologne, 50937, Cologne, Germany.
Anna EsserDepartment I of Internal Medicine, University of Cologne, 50937, Cologne, Germany.
Christoph HölscherGerman Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Melanie FritschCenter for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany.
Marc HerbExcellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931, Cologne, Germany.
Michael SchrammExcellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931, Cologne, Germany.
Laurens WachsmuthInstitute for Genetics, University of Cologne, 50674, Cologne, Germany.
Christian PallaschDepartment I of Internal Medicine, University of Cologne, 50937, Cologne, Germany.
Manolis PasparakisCenter for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany.ORCID http://orcid.org/0000-0002-9870-0966
Hamid KashkarCenter for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany.
Jan RybnikerDepartment I of Internal Medicine, University of Cologne, 50937, Cologne, Germany. jan.rybniker@uk-koeln.de.
University of Cologne · DEGerman Center for Infection Research · DETH Köln - University of Applied Sciences · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corticosteroids are host-directed drugs with proven beneficial effect on survival of tuberculosis (TB) patients, but their precise mechanisms of action in this disease remain largely unknown. Here we show that corticosteroids such as dexamethasone inhibit necrotic cell death of cells infected with Mycobacterium tuberculosis (Mtb) by facilitating mitogen-activated protein kinase phosphatase 1 (MKP-1)-dependent dephosphorylation of p38 MAPK. Characterization of infected mixed lineage kinase domain-like (MLKL) and tumor necrosis factor receptor 1 (TNFR1) knockout cells show that the underlying mechanism is independent from TNFα-signaling and necroptosis. Our results link corticosteroid function and p38 MAPK inhibition to abrogation of necrotic cell death mediated by mitochondrial membrane permeability transition, and open new avenues for research on novel host-directed therapies (HDT).

Indexed as

Adrenal Cortex HormonesDexamethasoneHumansMitochondrial MembranesMycobacterium tuberculosisp38 Mitogen-Activated Protein KinasesPhosphorylationReceptors, Tumor Necrosis Factor, Type ISignal TransductionAdrenal Cortex HormonesDexamethasonep38 Mitogen-Activated Protein KinasesReceptors, Tumor Necrosis Factor, Type I

Identifiers

PMID30737374
PMCPMC6368550
OpenAlexW2912054293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.